Search

Your search keyword '"Carlsson, Cynthia"' showing total 1,562 results

Search Constraints

Start Over You searched for: Author "Carlsson, Cynthia" Remove constraint Author: "Carlsson, Cynthia"
1,562 results on '"Carlsson, Cynthia"'

Search Results

51. Klotho protein concentrations as a function of sex, APOE, family history or Alzheimer’s disease biomarker status in an at‐risk cohort

52. Recruitment of Underrepresented Groups into the AHEAD Study: Strategic plan of Action

54. Two novel cerebrospinal fluid markers for vascular injury are associated with CSF markers of AD, neurodegeneration, and gliosis

55. Associations of Sleep Duration and Daytime Sleepiness with Plasma Amyloid Beta and Cognitive Performance in Cognitively Unimpaired, Middle-Aged and Older Adult African Americans

56. Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

59. Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer’s disease in late-middle-aged adults

61. Cross-sectional associations of CSF tau levels with Rey’s AVLT: A recency ratio study.

62. CSF metabolites associated with biomarkers of Alzheimer’s disease pathology

63. LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry

64. A comparison of diagnostic performance of word-list and story recall tests for biomarker-determined Alzheimer’s disease

65. Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals

66. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifiesLRRC4C, LHX5-AS1and nominates ancestry-specific lociPTPRK,GRB14, andKIAA0825as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium

67. Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA‐FAIM cohort

68. Transethnic genome-wide scan identifies novel Alzheimer's disease loci

70. Associations of sleep duration and daytime sleepiness with plasma amyloid beta and cognitive performance in cognitively unimpaired, middle-aged and older African Americans.

72. KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD

73. Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease

74. Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease.

75. Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment

76. Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation

78. Type 2 diabetes mellitus, brain atrophy, and cognitive decline

79. Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting

80. CSF SNAP‐25 Correlations with Synaptic Density by [11C]‐UCB‐J‐PET Imaging and AD Biomarkers.

81. Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups

82. Liver-Specific Polygenic Risk Score Is Associated with Alzheimer’s Disease Diagnosis

83. Associations between Recall of Proper Names in Story Recall and CSF Amyloid and Tau in a Cognitively Unimpaired Sample

85. Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention

87. An examination of baseline plasma Aβ42/40 and intra‐individual cognitive variability (IICV) associations with longitudinal cognitive change in a Black Cohort: Data from the African Americans Fighting Alzheimer’s in Midlife (AA‐FAIM) study

88. Associations between semantic memory for proper names in story recall and CSF amyloid and tau in a cognitively unimpaired sample

89. Diabetes is related to cognition but not plasma amyloid‐β 42/40 in an African American cohort

90. Relationships between psychosocial stress, cerebrospinal fluid markers of Alzheimer’s disease, and cognitive function in middle‐aged and older adults

92. Examining cerebrovascular burden across the cognitive continuum in older adults with and without evidence of amyloidosis

93. Assessing trust and research attitudes in Blacks/African Americans following a personalized vs less personalized community approach

94. Gut microbe‐modulated metabolites are longitudinally associated with higher neurodegeneration biomarkers in cerebrospinal fluid (CSF)

95. Cerebrospinal Fluid Sphingomyelins in Alzheimer’s Disease, Neurodegeneration, and Neuroinflammation1

96. Post-GWAS multiomic functional investigation of theTNIP1locus in Alzheimer’s disease implicates mediation throughGPX3

98. Amyloid burden and neural function in people at risk for Alzheimer's Disease

99. Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set

Catalog

Books, media, physical & digital resources